Coloma Jason V sold MAZE

May 26, 2026 · Form 4 insider transaction

Coloma Jason V sold 25,582 shares of Maze Therapeutics, Inc. at $26.02 per share, a transaction worth $665.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
25,582
Price
$26.02
Total value
$665.5K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 26, 2026
Filing dateMay 27, 2026
Shares owned after350,987
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.09 per share, inclusive.; These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

View the original Form 4 on SEC EDGAR